Europe Medical Cannabis Market, by Derivative

Growth Outlook

• The Europe Medical Cannabis Market, by Derivative market is on a steady long-term growth path. Segment value stands at roughly USD 5785 Mn in 2026 and is projected to reach USD 7328 Mn by 2027 — a gain of about 27% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Cannabidiol leads, holding roughly 72% of segment value — the single largest regional share. Tetrahydrocannabinol is the second-largest contributor.
• By 2027, Cannabidiol alone is expected to reach USD 5288 Mn, with Tetrahydrocannabinol at USD 2040 Mn.

Market Dynamics

The European medical cannabis market has been gaining traction in recent years due to the growing acceptance of cannabis for its medicinal properties. This demand is largely driven by the increasing awareness of the potential health benefits of cannabis and the growing number of countries legalizing its use for medical purposes. However, the demand for medical cannabis in Europe is not limited to traditional forms of consumption such as smoking or ingesting, but also includes various derivatives of the plant.

One of the most popular forms of medical cannabis is CBD oil. CBD, or cannabidiol, is a non-psychoactive compound found in cannabis that has been shown to have therapeutic effects such as reducing inflammation and pain, relieving anxiety and depression, and treating neurological disorders. In Europe, CBD oil is legal in most countries as long as it contains less than 0.2% of THC, the psychoactive compound found in cannabis. The demand for CBD oil has been steadily increasing, with many European countries seeing a rise in the number of CBD products available in the market.

Aside from CBD oil, another derivative of medical cannabis that is gaining demand in Europe is medical cannabis edibles. Edibles are food and drink products that have been infused with cannabis, making it easier and more discreet for patients to consume. This form of consumption is particularly popular among those who do not want to smoke but still want to experience the health benefits of cannabis. In Europe, the market for medical cannabis edibles is expected to grow as more countries are legalizing the use of cannabis for medical purposes.

Medical cannabis topicals, such as creams, lotions, and balms infused with cannabis extracts, are also in demand in Europe. These topicals are used for their anti-inflammatory and pain-relieving properties, making them popular among patients with skin conditions, arthritis, and other chronic pain issues. With the rising interest in alternative pain management treatments, the demand for medical cannabis topicals in Europe is expected to continue to grow.

Lastly, medical cannabis capsules and pills are becoming increasingly popular in Europe, especially among patients who are not comfortable with smoking or ingesting edibles. These capsules contain a measured dose of cannabis, making it convenient for patients to regulate their intake and monitor their effects. With the demand for non-smoking options increasing, the market for medical cannabis capsules and pills is expected to expand in the coming years.

In conclusion, the Europe medical cannabis market is not limited to traditional forms of consumption, but also includes various derivatives that cater to the changing preferences of consumers. With the demand for medical cannabis expected to grow, it is evident that the market for its derivatives will also continue to expand and evolve.